Fig. 7
Effect of LIVP-GFP treatment on the immune responses of tumour-bearing mice. a Summary data showing a significant increase of the number of IFN-γ-ransecreting splenocytes in LIVP-GFP-treated mice (n = 6) with RLS-40 or with melanoma B-16 tumours. Comparison of immune-related proteins GMC-SF (b) and IL-6 (c) in the blood serum of RLS-40 bearing mice during the treatment with LIVP-GFP (the experimental scheme was shown in Fig. 5a): red circles and blue squares for RLS-40 bearing mice treated with LIVP-GFP and PBS, respectively; black triangles healthy mice receiving PBS. The levels of cytokines in the blood serum were measured by ELISA. For each day, the value of mean ± SEM is shown